The Genetics Company
Latest round
- Series C
Last raised
- Jun 2007
Total raised
- $34M
Investors
- 6
About The Genetics Company
The Genetics Company Inc.The Genetics Company Inc. specializes in developing biopharmaceutical products targeting neurodegenerative diseases and cancers. The company is headquartered in Basel, Switzerland.The Genetics Company specializes in the research, development, and commercialization of innovative biopharmaceutical products aimed at diagnosing, monitoring, and treating neurodegenerative diseases such as Alzheimer's disease and various forms of cancer, notably colorectal cancer. Key offerings include small molecule Wnt-inhibitors designed to target the aberrant Wnt signaling pathway in colorectal cancer, small molecule BACE inhibitors that inhibit the ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) for Alzheimer's treatment, and a range of small molecule inhibitors that regulate cellular growth in cancer therapy. These products aim to address critical unmet medical needs, specifically targeting the underlying biological mechanisms that contribute to disease progression.The Genetics Company generates revenue through the sale of its specialized therapeutics and partnerships with healthcare institutions and pharmaceutical companies. Transactions typically occur through B2B partnerships where healthcare providers and pharmaceutical companies acquire therapeutic products for clinical applications. The company may offer tiered pricing plans for its small molecule therapeutics, structured to accommodate bulk purchases by hospitals and research facilities, promoting accessibility and uptake in diverse healthcare settings.In the future, The Genetics Company plans to launch new products focused on expanding its range of therapeutics for neurodegenerative diseases and cancers. The company is also targeting expansion into Asian markets by 2025, aiming to increase accessibility of its innovative therapeutics in underserved regions.
Who invested in The Genetics Company
6 investors across 5 rounds
See all investors in The Genetics Company
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about The Genetics Company
Who invested in The Genetics Company?
The Genetics Company has 6 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has The Genetics Company raised?
The Genetics Company has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did The Genetics Company last raise money?
The Genetics Company's most recent round on record is a Series C, in Jun 2007.
What does The Genetics Company do?
The Genetics Company is a biotechnology company.
Where is The Genetics Company headquartered?
The Genetics Company is headquartered in Basel, Switzerland.
Which VCs invest in companies like The Genetics Company?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at The Genetics Company's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like The Genetics Company? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.